Ethris and Lonza have announced a collaboration to develop room-temperature stable, spray-dried formulations of mRNA-based vaccine candidates, designed for mucosal delivery that offer a promising approach to combat respiratory diseases.
Kindeva Drug Delivery and Emervax have announced an exclusive partnership to co-develop a solution for the administration of vaccines targeting a variety of emerging viruses.
Kindeva Drug Delivery and Emervax has announced an exclusive partnership to co-develop a solution for the administration of vaccines targeting a variety of emerging viruses.
NEC Bio Therapeutics presents 24-week promising interim results from an ongoing Phase 1 basket clinical trial of an orally administered cancer vaccine, NECVAX-NEO1.
The Infection Innovation Consortium: iiCON is managing a new £3.2 million Medical Research Council funded trial to enable progress into development of a new vaccine against pneumococcal disease.
Infinitopes’ lead vaccine candidate ITOP1 is a novel, precision targeted “off-the-shelf” cancer vaccine, designed to save lives by preventing disease recurrence in first-line patients with surgically resectable cancers.
VALANX Biotech and FinaBio sign joint licensing agreement to commercialise ready-to-conjugate vaccine carrier protein CRM197 will enable rapid development of conjugate vaccines.
Naobios and Sumagen Canada Inc, a Korean-Canadian biotechnology company developing an HIV-1 vaccine candidate, announced the production of the HIV-1 vaccine candidate at bench scale.
The FDA has expanded approval for Pfizer’s respiratory syncytial virus (RSV) vaccine, Abrysvo, to include adults aged 18–59 years who are at higher risk of lower respiratory tract disease from the virus due to chronic conditions.
Patients receiving treatment for bowel cancer at Sheffield Teaching Hospitals NHS Foundation Trust will have the chance to try personalised 'vaccines' thanks to the launch of a NHS “matchmaking” service.
In partnership with the Sabin Vaccine Institute, ReiThera provided its investigational Marburg vaccine to Rwanda to support the ongoing outbreak response.
